Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
James Q Del Rosso, Waranush Jitpraphai, Sanjay Bhambri, Saira Momin
Index: Cutis. 81(5) , 405-8, (2008)
Full Text: HTML
Abstract
An aqueous gel formulation containing solubilized clindamycin phosphate 1.2% and a stable combination of both solubilized and crystalline tretinoin 0.025% (clin/tret) has been evaluated in 3 pivotal phase 3 studies, among other studies including a 52-week trial. The pivotal studies enrolled 4550 participants 12 years and older with mild, moderate, and severe acne vulgaris. The combination clin/tret gel was effective in reducing both inflammatory and noninflammatory lesions and was well-tolerated. This article reviews important vehicle characteristics of the combination gel as well as formulation stability and tolerability data that are potentially clinically relevant.
Related Compounds
Related Articles:
2011-03-11
[J. Biol. Chem. 286(10) , 7822-9, (2011)]
2012-08-17
[J. Chromatogr. A. 1251 , 244-8, (2012)]
2014-08-22
[J. Chromatogr. A. 1356 , 289-93, (2014)]
1998-12-01
[Can. Vet. J. 39(12) , 753-6, (1998)]
2014-02-01
[J. Pharm. Sci. 103(2) , 567-79, (2014)]